Cite
HARVARD Citation
Steere, B. et al. (n.d.). DOP86 Mirikizumab-induced upregulation of colonic transcripts correlates with improvements in stool frequency in a phase 2 study of patients with moderately to severely active Ulcerative Colitis. Journal of Crohn's and colitis. p. i129. [Online].